IndraLab

Statements

CRMA inhibits CYLD. 1 / 1

| 1

reach

"CrmA prevented processing of CYLD to CYLDp25 (XREF_SUPPLEMENTARY) whereas an aspartate to alanine mutation that abrogates the ability of CrmA to inhibit CASPASE 8 (CrmA-D303A) was unable to prevent cleavage of CYLD."

22037414

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CRMA inhibits CYLD. 1 / 1

INDRA sources:

Databases

Reading